4//SEC Filing
Tak Paul Peter 4
Accession 0000899243-22-008373
CIK 0001841387other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:35 PM ET
Size
6.2 KB
Accession
0000899243-22-008373
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+330,000→ 330,000 totalExercise: $4.12Exp: 2032-02-28→ Common Stock (330,000 underlying)
Footnotes (1)
- [F1]This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873905
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 6:35 PM ET
- Size
- 6.2 KB